{"id":"W2007340026","doi":"10.1177/1756283x08092548","title":"Review: Efficacy and safety of adalimumab in Crohn's disease","year":2008,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Concomitant; Crohn's disease; Placebo; Internal medicine; Monoclonal antibody; Gastroenterology; Immunogenicity; Population; Tumor necrosis factor alpha; Antibody; Surgery; Disease; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001494853,0.0001479023,0.0002400668,0.00006095867,0.00002273162,0.000001003936,0.0001532912,0.00004774201,0.00001681995],"category_scores_gemma":[0.00004346711,0.000144461,0.00004504469,0.00005348435,0.0003254364,0.000009458275,0.00007936911,0.00008922041,0.000001505279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001413505,"about_ca_system_score_gemma":0.00003853261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001929291,"about_ca_topic_score_gemma":0.00007492729,"domain_scores_codex":[0.9988194,0.0001982232,0.0003492693,0.0002900749,0.00006993033,0.0002731265],"domain_scores_gemma":[0.9994786,0.00001634123,0.0001041416,0.0002949852,0.00002704583,0.00007884091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01293413,0.0003278634,0.9756802,0.0004836595,0.00003306177,0.0004418502,0.00007206371,0.0004606811,0.001876616,0.00009530794,0.00006565451,0.007528955],"study_design_scores_gemma":[0.002937778,0.0001936366,0.9913359,0.000202949,0.00001654104,0.00003186284,0.000009660461,0.0000274533,0.00005731437,0.0001261721,0.004968091,0.0000926916],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.950179,0.04887072,0.0003416342,0.0001290852,0.00005668855,0.0003311748,0.0000140286,0.000005301922,0.00007239293],"genre_scores_gemma":[0.9239369,0.07414056,0.0001357212,0.001676087,0.00002697248,0.00003202045,0.00002210507,0.00001382103,0.00001580909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02624207,"threshold_uncertainty_score":0.5890948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008379344914020771,"score_gpt":0.2645594977694259,"score_spread":0.2561801528554052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}